Nipah Virus is More Deadly than Covid-19, Expert Says

Ilustrasi virus nipah
Sumber :
  • Pixabay

India – Recently, the Nipah Virus has killed two people in India. Nipah is a rare and potentially deadly virus that was first discovered in 1999 after an outbreak among pigs and pig farmers in Malaysia and Singapore. 

img_title Truk di India Tabrak Kerumunan Peziarah, 15 Orang Tewas-27 Luka

This virus is a zoonotic virus that can spread from animals to humans and can infect humans through direct contact with infected animals or their bodily fluids or after eating contaminated food as fruit products contaminated with urine or saliva from infected bats. 

ADVERTISEMENT

GULIR UNTUK LANJUT BACA

The Indian Council of Medical Research (ICMR) Director General, Dr. Rajeev Bahl, said that the mortality rate of the Nipah virus is very high, compared to Covid-19. 

img_title Berdesakan di Festival Keagamaan di India, 17 Orang Tewas

The mortality rate of the Nipah virus is estimated to be between 40 percent and 75 percent, while the mortality rate of Covid-19 is around 2-3 percent. 

Virus Nipah

Photo :
  • Indian Express

img_title Pesawat Air India Alihkan Penerbangan usai Pilot Kirim Kode Pembajakan

This means that Nipah virus is a much more deadly disease than Covid-19. However, it is important to note that the Nipah virus is also much less transmissible than Covid-19.

Nipah virus is spread through direct contact with infected bats or pigs, or contaminated food or water. Covid-19, on the other hand, is spread through respiratory droplets produced when an infected person coughs or sneezes.

The symptoms of the Nipah virus are similar to Covid-19, such as cough, sore throat, dizziness, drowsiness, muscle pain, tiredness, encephalitis (swelling of the brain), headache, stiff neck, sensitivity to light, mental confusion, and seizures.

"We don't know why the cases keep surfacing. In 2018, we found the outbreak in Kerala was related to bats. We are not sure how the infection passed from bats to humans," Bahl informed. 

ADVERTISEMENT

GULIR UNTUK LANJUT BACA

According to him, India would obtain 20 additional doses of monoclonal antibody from Australia for the treatment of Nipah virus infection.

“We got some doses of monoclonal antibody from Australia in 2018. Currently, the doses are available for only 10 patients," he remarked. 

Halaman Selanjutnya
Halaman Selanjutnya
Jadikan Viva News & Insight sumber pilihan di Google
Lanjut